XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Index movements reflect changes in component stock prices, earnings, macro data, and capital flows. This overview highlights the main drivers behind daily swings.
18,176 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Markets tremble as macro fears and geopolitics rise. Three safer dividend ETFs to pursue offer steadier income, lower...
In 2026, three popular tech ETFs tell three different stories about how to own technology: FTEC offers broad exposure...
With rate headlines dominating markets, experts say three actionable moves beat guessing games: automate saving, dive...
Healthcare sector ETFs offer defense and income, but not all are created equal. This article dives into how state str...
As AI stocks drive gains, traders debate whether equal-weighted ETFs like RSP can outpace SPY’s cap-weighted edge. He...
Tech stocks just their footing as an AI spending surge loses steam. The sector faced a rough week, driven by slower d...
Tech stocks retreat as geopolitical tensions escalate and oil climbs, sending the live nasdaq composite: tech lower a...
Meet a disciplined wealth-builder who turned ambitious plans into real results. This millionaire interview uncovers p...
Global markets wobble as Iran-related tensions flare, pushing equities toward correction while traders turn to option...
The VIX slid as optimism about geopolitical peace and cheaper oil spurred a broad market rally. Analysts caution the ...
When a seasoned manager shifts more weight toward mid-cap stocks, the move often signals conviction about the sector'...